======= OTUD7B =======
== Gene Information ==
* **Official Symbol**: OTUD7B
* **Official Name**: OTU deubiquitinase 7B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56957|56957]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q6GQQ9|Q6GQQ9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=OTUD7B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20OTUD7B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/611748|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Negative regulator of the non-canonical NF-kappa-B pathway that acts by mediating deubiquitination of TRAF3, an inhibitor of the NF-kappa-B pathway, thereby acting as a negative regulator of B-cell responses. In response to non-canonical NF- kappa-B stimuli, deubiquitinates 'Lys-48'-linked polyubiquitin chains of TRAF3, preventing TRAF3 proteolysis and over-activation of non-canonical NF-kappa-B. Negatively regulates mucosal immunity against infections (By similarity). Deubiquitinates ZAP70, and thereby regulates T cell receptor (TCR) signaling that leads to the activation of NF-kappa-B (PubMed:26903241). Plays a role in T cell homeostasis and is required for normal T cell responses, including production of IFNG and IL2 (By similarity). Mediates deubiquitination of EGFR (PubMed:22179831). Has deubiquitinating activity toward 'Lys-11', 'Lys-48' and 'Lys-63'-linked polyubiquitin chains (PubMed:27732584). Has a much higher catalytic rate with 'Lys-11'-linked polyubiquitin chains (in vitro); however the physiological significance of these data are unsure (PubMed:27732584). Hydrolyzes both linear and branched forms of polyubiquitin. {ECO:0000250|UniProtKB:B2RUR8, ECO:0000269|PubMed:11463333, ECO:0000269|PubMed:12682062, ECO:0000269|PubMed:18178551, ECO:0000269|PubMed:20622874, ECO:0000269|PubMed:22179831, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:27732584}.
|OTU|
|protein deubiquitination involved in ubiquitin-dependent protein catabolic process|
|protein K11-linked deubiquitination|
|Lys48-specific deubiquitinase activity|
|negative regulation of interleukin-8 production|
|K63-linked polyubiquitin modification-dependent protein binding|
|mucosal immune response|
|negative regulation of protein localization to nucleus|
|cysteine-type peptidase activity|
|protein K63-linked deubiquitination|
|organ or tissue specific immune response|
|protein K48-linked deubiquitination|
|negative regulation of I-kappaB kinase/NF-kappaB signaling|
|thiol-dependent ubiquitinyl hydrolase activity|
|regulation of interleukin-8 production|
|thiol-dependent ubiquitin-specific protease activity|
|negative regulation of cellular protein localization|
|regulation of protein localization to nucleus|
|regulation of I-kappaB kinase/NF-kappaB signaling|
|negative regulation of cytokine production|
|protein deubiquitination|
|protein modification by small protein removal|
|in utero embryonic development|
|negative regulation of intracellular signal transduction|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|regulation of cellular protein localization|
|modification-dependent macromolecule catabolic process|
|proteolysis involved in cellular protein catabolic process|
|adaptive immune response|
|cellular protein catabolic process|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|protein catabolic process|
|regulation of cytokine production|
|zinc ion binding|
|negative regulation of transcription by RNA polymerase II|
|cellular macromolecule catabolic process|
|regulation of cellular localization|
|embryo development|
|protein modification by small protein conjugation or removal|
|regulation of protein localization|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|negative regulation of transcription, DNA-templated|
|negative regulation of multicellular organismal process|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of signal transduction|
|proteolysis|
|negative regulation of RNA metabolic process|
|negative regulation of cell communication|
|negative regulation of signaling|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of response to stimulus|
|negative regulation of gene expression|
|organic substance catabolic process|
|cellular catabolic process|
|regulation of intracellular signal transduction|
|immune response|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp293|Myriocin 25μM R06 exp293]]|-2.36|
|[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-1.72|
|[[:results:exp83|Trametinib 10μM R02 exp83]]|1.83|
|[[:results:exp534|Trientine 500μM R08 exp534]]|1.89|
|[[:results:exp113|1-Methyl-nicotinamide-chloride 1000μM R03 exp113]]|1.95|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7516
* **Expression level (log2 read counts)**: 3.4
{{:chemogenomics:nalm6 dist.png?nolink |}}